ABVX logo

ABIVAX SA (ABVX)

Profile

Full Name

ABIVAX Société Anonyme

Ticker Symbol

ABVX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

October 20, 2023

Indexes

Not included

Website

http://www.abivax.com

Employees

69

Key Details

Price

$6.25(+3.22%)

Market cap

$396.68M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.03(+18.39% YoY)

PE ratio

-

Next earnings date

Jun 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.25
ABVX price is $6.25

30-Day Relative Volume

0.42
ABVX 30-day relative volume is 0.42

Price Performance

Price Most recent change

+3.22%
ABVX price was up +3.22% on Apr 16, 2025

Price YTD change

-14.55%
ABVX price is down -14.55% since January 1st

Price 1-year change

-57.54%
ABVX price is down -57.54% year-on-year

Price 3-year change

-
ABVX price 3-year change is unknown

Price Range

Price All-time high

$17.02
ABVX price is currently -63.25% below its historical high of $17.02

Price 3-year low

$4.77
ABVX price is currently +31.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$396.68M
ABVX market capitalization is $396.68 million

Market cap 3-year change

-
ABVX market capitalization 3-year change is unknown

Market cap All-time high

$999.76M
ABVX market capitalization is currently -60.32% below its historical high of $999.76 million

Market cap sector rank

66.53%
ABVX market capitalization is higher than 66.53% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.8%
ABVX shares outstanding is up +0.8% year-on-year

Shares Outstanding 3-Year Change

+278.49%
ABVX shares outstanding is up +278.49% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.02
ABVX beta is 1.02

200-day SMA

$9.16
ABVX price is currently -31.69% below its 200-day simple moving average

50-day SMA

$6.71
ABVX price is currently -6.74% below its 50-day simple moving average

RSI

50.02
ABVX 14-day relative strength index is 50.02

Volume

0.42
ABVX 30-day relative volume is 0.42

ATR

$0.61
ABVX average true range is $0.61

10-day Historical Volatility

98.12%
ABVX 10-day historical volatility is 98.12%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ABVX annual revenue value is unknown

Revenue Analysts estimate

$7.24M
ABVX annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
ABVX annual revenue 1-year change is unknown

Revenue Sector rank

-
ABVX annual revenue is unknown

EPS

EPS

-$3.03
ABVX annual earnings per share is -$3.03

EPS Analysts estimate

-$3.20
ABVX annual earnings per share is currently -5.26% lower than the consensus analysts' forecast

EPS 1-year change

+18.39%
ABVX annual earnings per share is up +18.39% year-on-year

EPS Sector rank

29.08%
ABVX annual earnings per share is higher than 29.08% of companies in Healthcare sector

Profit

Gross profit

-
ABVX annual gross profit value is unknown

Gross margin

-
ABVX annual gross profit margin value is unknown

Operating profit

-$187.23M
ABVX annual operating income is -$187.23 million

Operating margin

-
ABVX annual operating profit margin value is unknown

Net income

-$190.76M
ABVX annual net profit is -$190.76 million

Net margin

-
ABVX annual net profit margin value is unknown

Expenses

Total expenses

$187.23M
ABVX annual total expenses is $187.23 million

Operating expenses

$187.23M
ABVX annual total operating expenses is $187.23 million

Cost of goods sold

-
ABVX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$42.10M
ABVX annual SGA is $42.10 million

Depreciation and amortization

$1.19M
ABVX annual depreciation & amortization is $1.19 million

Interest expense

$13.45M
ABVX annual interest expense is $13.45 million

Income tax

$0.00
ABVX annual income tax is $0.00

EBIT & EBITDA

EBIT

-$177.30M
ABVX annual earnings before interest & taxes is -$177.30 million

EBITDA

-$176.11M
ABVX annual EBITDA is -$176.11 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$213.55M
ABVX annual total assets is $213.55 million

Non current assets

$35.96M
ABVX annual long term assets is $35.96 million

Current assets

$177.60M
ABVX annual total current assets is $177.60 million

Cash and cash equivalents

$150.07M
ABVX annual cash & cash equivalents is $150.07 million

Accounts receivable

-
ABVX annual accounts receivable value is unknown

Inventory

-
ABVX annual inventory value is unknown

Liabilities

Total liabilities

$171.32M
ABVX annual total liabilities is $171.32 million

Long term liabilities

$74.72M
ABVX annual total long term liabilities is $74.72 million

Current liabilities

$96.60M
ABVX annual total current liabilities is $96.60 million

Accounts payable

$45.60M
ABVX annual accounts payable is $45.60 million

Debt

Total debt

$101.31M
ABVX annual total debt is $101.31 million

Total debt 1-year change

+57.9%
ABVX annual total debt is up +57.9% year-on-year

Long term debt

$55.77M
ABVX annual long term debt is $55.77 million

Short term debt

$45.54M
ABVX annual short term debt is $45.54 million

Equity & Capital

Shareholders equity

$42.23M
ABVX annual stockholders equity is $42.23 million

Book value

$42.23M
ABVX annual book value is $42.23 million

Retained earnings

-$456.68M
ABVX annual retained earnings is -$456.68 million

Working capital

$80.99M
ABVX annual working capital is $80.99 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$166.76M
ABVX annual cash flow from operations is -$166.76 million

Cash from operations 1-year change

-58.59%
ABVX annual cash flow from operations is down -58.59% year-on-year

Cash from investing

$17.06M
ABVX annual cash flow from investing activities is $17.06 million

Cash from investing 1-year change

+294.67%
ABVX annual cash flow from investing activities is up +294.67% year-on-year

Cash from financing

$30.53M
ABVX annual cash flow from financing activities is $30.53 million

Cash from financing 1-year change

-91.59%
ABVX annual cash flow from financing activities is down -91.59% year-on-year

CAPEX

CAPEX

-
ABVX annual capital expenditures value is unknown

CAPEX 1-year change

-
ABVX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$167.46M
ABVX annual free cash flow is -$167.46 million

Free cash flow 1-year change

-58.82%
ABVX annual free cash flow is down -58.82% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ABVX annual gross profit margin value is unknown

Operating margin

-
ABVX annual operating profit margin value is unknown

Net margin

-
ABVX annual net profit margin value is unknown

ROA & ROE

ROA

-89.32%
ABVX annual return on assets is -89.32%

ROE

-451.70%
ABVX annual return on equity is -451.70%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ABVX price to earnings ratio value is unknown

PE ratio Sector rank

-
ABVX price to earnings ratio is unknown

PB Ratio

PB ratio

1.83
ABVX price to book ratio is 1.83

PB ratio Sector rank

60.66%
ABVX price to book ratio is higher than 60.66% of companies in Healthcare sector

PS Ratio

PS ratio

-
ABVX price to sales ratio value is unknown

PS ratio Sector rank

-
ABVX price to sales ratio is unknown

Enterprise value

Enterprise value

$202.33M
ABVX enterprise value is $202.33 million

Enterprise value Sector rank

59.39%
ABVX enterprise value is higher than 59.39% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
ABVX EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
ABVX EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.84
ABVX annual current ratio is 1.84

Quick ratio

-
ABVX annual quick ratio value is unknown

Leverage

Debt to equity

2.40
ABVX annual debt to equity ratio is 2.40

Interest coverage ratio

-13.18
ABVX annual interest coverage ratio is -13.18

Risk & Stability

Piotroski F-Score

-
ABVX piotroski f-score value is unknown

Altman Z-Score

-
ABVX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 18, 25 Citizens Capital Markets
Market Outperform
Jan 10, 25 JMP Securities
Market Outperform
Dec 4, 24 JMP Securities
Market Outperform
Jul 29, 24 Laidlaw & Co.
Buy
May 20, 24 BTIG
Buy
Apr 29, 24 Piper Sandler
Overweight
Apr 29, 24 Guggenheim
Buy
Apr 11, 24 Morgan Stanley
Equal-Weight
Nov 14, 23 Morgan Stanley
Equal-Weight
Nov 14, 23 Leerink Partners
Outperform

Institutional Ownership

Similar stocks

VERV logo
Verve Therapeutics (VERV)
OMER logo
Omeros (OMER)
PRTC logo
PureTech Health (PRTC)
OnKure Therapeutics (OKUR)
SRDX logo
Surmodics (SRDX)
PGEN logo
Precigen (PGEN)
Beta Bionics (BBNX)
Enhabit (EHAB)
ABSI logo
Absci (ABSI)
  • What is the ticker symbol for ABIVAX SA?
  • Does ABIVAX SA pay dividends?
  • What sector is ABIVAX SA in?
  • What industry is ABIVAX SA in?
  • What country is ABIVAX SA based in?
  • When did ABIVAX SA go public?
  • Is ABIVAX SA in the S&P 500?
  • Is ABIVAX SA in the NASDAQ 100?
  • Is ABIVAX SA in the Dow Jones?
  • When was ABIVAX SA's last earnings report?
  • When does ABIVAX SA report earnings?

What is the ticker symbol for ABIVAX SA?

The ticker symbol for ABIVAX SA is NASDAQ:ABVX

Does ABIVAX SA pay dividends?

No, ABIVAX SA does not pay dividends

What sector is ABIVAX SA in?

ABIVAX SA is in the Healthcare sector

What industry is ABIVAX SA in?

ABIVAX SA is in the Biotechnology industry

What country is ABIVAX SA based in?

ABIVAX SA is headquartered in France

When did ABIVAX SA go public?

ABIVAX SA's initial public offering (IPO) was on October 20, 2023

Is ABIVAX SA in the S&P 500?

No, ABIVAX SA is not included in the S&P 500 index

Is ABIVAX SA in the NASDAQ 100?

No, ABIVAX SA is not included in the NASDAQ 100 index

Is ABIVAX SA in the Dow Jones?

No, ABIVAX SA is not included in the Dow Jones index

When was ABIVAX SA's last earnings report?

ABIVAX SA's most recent earnings report was on Mar 24, 2025

When does ABIVAX SA report earnings?

The next expected earnings date for ABIVAX SA is Jun 2, 2025
On this page